The Transcriptional Regulation of B Cell Lineage Commitment (DOI:10.1016/j.immuni.2007.05.010);The Transcriptional Regulation of B Cell Lineage Commitment

Immunity

Volumn 26, Issue 6, 2007, Pages 715-725

  Nutt, Stephen L ^a   Kee, Barbara L ^b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Cancer Biology and Developmental Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CHEMOKINE RECEPTOR CCR9; DNA BINDING PROTEIN; GROWTH FACTOR RECEPTOR; IKAROS TRANSCRIPTION FACTOR; L SELECTIN; LYMPHOID ENHANCER FACTOR 1; RAG1 PROTEIN; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR SOX4;

APOPTOSIS; B LYMPHOCYTE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL RENEWAL; CELL SURVIVAL; DENDRITIC CELL; DNA BINDING; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MULTIPOTENT STEM CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 34250212629     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.07.006     Document Type: Erratum

References (104)

1. Adolfsson J., Borge O.J., Bryder D., Theilgaard-Monch K., Astrand-Grundstrom I., Sitnicka E., Sasaki Y., and Jacobsen S.E. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15 (2001) 659-669
2. Adolfsson J., Mansson R., Buza-Vidas N., Hultquist A., Liuba K., Jensen C.T., Bryder D., Yang L., Borge O.J., Thoren L.A., et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121 (2005) 295-306
3. Akashi K., Traver D., Miyamoto T., and Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404 (2000) 193-197
4. Allman D., Sambandam A., Kim S., Miller J.P., Pagan A., Well D., Meraz A., and Bhandoola A. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4 (2003) 168-174
5. Back J., Allman D., Chan S., and Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp. Hematol. 33 (2005) 395-402
6. Bain G., Maandag E.C., Izon D.J., Amsen D., Kruisbeek A.M., Weintraub B.C., Krop I., Schlissel M.S., Feeney A.J., van Roon M., et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79 (1994) 885-892
7. Bain G., Robanus Maandag E.C., te Riele H.P., Feeney A.J., Sheehy A., Schlissel M., Shinton S.A., Hardy R.R., and Murre C. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6 (1997) 145-154
8. Balciunaite G., Ceredig R., Massa S., and Rolink A.G. A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur. J. Immunol. 35 (2005) 2019-2030
9. Bhandoola A., von Boehmer H., Petrie H.T., and Zúñiga-Pflücker J.C. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: Plenty to choose from. Immunity 26 (2007) 678-689 this issue
10. Borghesi L., Aites J., Nelson S., Lefterov P., James P., and Gerstein R. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J. Exp. Med. 202 (2005) 1669-1677
11. Brown K.E., Guest S.S., Smale S.T., Hahm K., Merkenschlager M., and Fisher A.G. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91 (1997) 845-854
12. Ceredig R., Rauch M., Balciunaite G., and Rolink A.G. Increasing Flt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment. Blood 108 (2006) 1216-1222
13. Clark M.R., Cooper A.B., Wang L.D., and Aifantis I. The pre-B cell receptor in B cell development: Recent advances, persistent questions and conserved mechanisms. Curr. Top. Microbiol. Immunol. 290 (2005) 87-103
14. Cobaleda C., Schebesta A., Delogu A., and Busslinger M. Pax5: The guardian of B cell identity and function. Nat. Immunol. 8 (2007) 463-470
15. Dakic A., Metcalf D., Di Rago L., Mifsud S., Wu L., and Nutt S.L. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201 (2005) 1487-1502
16. Dakic A., Wu L., and Nutt S.L. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?. Trends Immunol. 28 (2007) 108-114
17. DeKoter R.P., Lee H.J., and Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16 (2002) 297-309
18. DeKoter R.P., and Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288 (2000) 1439-1441
19. Delogu A., Schebesta A., Sun Q., Aschenbrenner K., Perlot T., and Busslinger M. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24 (2006) 269-281
20. Dias S., Silva Jr. H., Cumano A., and Vieira P. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J. Exp. Med. 201 (2005) 971-979
21. Fitzsimmons D., Hodsdon W., Wheat W., Maira S.M., Wasylyk B., and Hagman J. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10 (1996) 2198-2211
22. Fuxa M., and Busslinger M. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function. J. Immunol. 178 (2007) 3031-3037
23. Fuxa M., Skok J., Souabni A., Salvagiotto G., Roldan E., and Busslinger M. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18 (2004) 411-422
24. Geijsen N., Uings I.J., Pals C., Armstrong J., McKinnon M., Raaijmakers J.A., Lammers J.W., Koenderman L., and Coffer P.J. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 293 (2001) 1136-1138
25. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., and Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79 (1994) 143-156
26. Gounari F., Aifantis I., Martin C., Fehling H.J., Hoeflinger S., Leder P., von Boehmer H., and Reizis B. Tracing lymphopoiesis with the aid of a pTalpha-controlled reporter gene. Nat. Immunol. 3 (2002) 489-496
27. Hagman J., Belanger C., Travis A., Turck C.W., and Grosschedl R. Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev. 7 (1993) 760-773
28. Hagman J., and Lukin K. Early B-cell factor 'pioneers' the way for B-cell development. Trends Immunol. 26 (2005) 455-461
29. Hardy R.R., Kincade P.W., and Dorshkind K. The protean nature of cells in the B lymphocyte lineage. Immunity 26 (2007) 703-714 this issue
30. Harker N., Naito T., Cortes M., Hostert A., Hirschberg S., Tolaini M., Roderick K., Georgopoulos K., and Kioussis D. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol. Cell 10 (2002) 1403-1415
31. Harman B.C., Miller J.P., Nikbakht N., Gerstein R., and Allman D. Mouse plasmacytoid dendritic cells derive exclusively from estrogen-resistant myeloid progenitors. Blood 108 (2006) 878-885
32. Hirokawa S., Sato H., Kato I., and Kudo A. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells. Eur. J. Immunol. 33 (2003) 1824-1829
33. Holmes M.L., Carotta S., Corcoran L.M., and Nutt S.L. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev. 20 (2006) 933-938
34. Houston I.B., Kamath M., Schweitzer B.L., Chlon T.M., and DeKoter R.P. Reduction in PU.1 activity results in a block to B cell development, abnormal myeloid proliferation and neonatal lethality. Exp. Hematol. (2007) in press
35. Hsu L.Y., Lauring J., Liang H.E., Greenbaum S., Cado D., Zhuang Y., and Schlissel M.S. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19 (2003) 105-117
36. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., and Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11 (1997) 774-785
37. Igarashi H., Gregory S.C., Yokota T., Sakaguchi N., and Kincade P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17 (2002) 117-130
38. Ikawa T., Kawamoto H., Wright L.Y., and Murre C. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20 (2004) 349-360
39. Iwasaki H., Somoza C., Shigematsu H., Duprez E.A., Iwasaki-Arai J., Mizuno S., Arinobu Y., Geary K., Zhang P., Dayaram T., et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106 (2005) 1590-1600
40. Kallies A., Hasbold J., Fairfax K., Pridans C., Emslie D., McKenzie B.S., Lew A.M., Corcoran L.M., Hodgkin P.D., Tarlinton D.M., and Nutt S.L. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. Immunity 26 (2007) 555-566
41. Kang J., and Der S.D. Cytokine functions in the formative stages of a lymphocyte's life. Curr. Opin. Immunol. 16 (2004) 180-190
42. Kee B.L. Id3 induces growth arrest and caspase-2-dependent apoptosis in B lymphocyte progenitors. J. Immunol. 175 (2005) 4518-4527
43. Kee B.L., and Murre C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188 (1998) 699-713
44. Kikuchi K., Lai A.Y., Hsu C.L., and Kondo M. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J. Exp. Med. 201 (2005) 1197-1203
45. Kim J., Sif S., Jones B., Jackson A., Koipally J., Heller E., Winandy S., Viel A., Sawyer A., Ikeda T., et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10 (1999) 345-355
46. Kirstetter P., Thomas M., Dierich A., Kastner P., and Chan S. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32 (2002) 720-730
47. Kondo M., Weissman I.L., and Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91 (1997) 661-672
48. Laiosa C.V., Stadtfeld M., and Graf T. Determinants of lymphoid-myeloid lineage diversification. Annu. Rev. Immunol. 24 (2006) 705-738
49. Lazorchak A.S., Wojciechowski J., Dai M., and Zhuang Y. E2A promotes the survival of precursor and mature B lymphocytes. J. Immunol. 177 (2006) 2495-2504
50. Li Y.S., Wasserman R., Hayakawa K., and Hardy R.R. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5 (1996) 527-535
51. Lin H., and Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376 (1995) 263-267
52. Liu P., Keller J.R., Ortiz M., Tessarollo L., Rachel R.A., Nakamura T., Jenkins N.A., and Copeland N.G. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4 (2003) 525-532
53. Mackarehtschian K., Hardin J.D., Moore K.A., Boast S., Goff S.P., and Lemischka I.R. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3 (1995) 147-161
54. Maier H., Ostraat R., Gao H., Fields S., Shinton S.A., Medina K.L., Ikawa T., Murre C., Singh H., Hardy R.R., and Hagman J. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5 (2004) 1069-1077
55. Mansson R., Hultquist A., Luc S., Yang L., Anderson K., Kharazi S., Al-Hashmi S., Liuba K., Thoren L., Adolfsson J., et al. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 26 (2007) 407-419
56. Martensson A., Xie X.Q., Persson C., Holm M., Grundstrom T., and Martensson I.L. PEBP2 and c-myb sites crucial for lambda5 core enhancer activity in pre-B cells. Eur. J. Immunol. 31 (2001) 3165-3174
57. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., Maliszewski C.R., Lynch D.H., Smith J., Pulendran B., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95 (2000) 3489-3497
58. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., and Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15 (1996) 5647-5658
59. Medina K.L., Pongubala J.M., Reddy K.L., Lancki D.W., Dekoter R., Kieslinger M., Grosschedl R., and Singh H. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7 (2004) 607-617
60. Mikkola I., Heavey B., Horcher M., and Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science 297 (2002) 110-113
61. Molnar A., and Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell. Biol. 14 (1994) 8292-8303
62. Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E., Dalton J.D., Girtman K., Mathew S., Ma J., Pounds S.B., et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446 (2007) 758-764
63. Nera K.P., Kohonen P., Narvi E., Peippo A., Mustonen L., Terho P., Koskela K., Buerstedde J.M., and Lassila O. Loss of Pax5 promotes plasma-cell differentiation. Immunity 24 (2006) 283-293
64. Ng S.Y., Yoshida T., and Georgopoulos K. Ikaros and chromatin regulation in early hematopoiesis. Curr. Opin. Immunol. 19 (2007) 116-122
65. Nutt S.L., Heavey B., Rolink A.G., and Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401 (1999) 556-562
66. Nutt S.L., Metcalf D., D'Amico A., Polli M., and Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 201 (2005) 221-231
67. Nutt S.L., Morrison A.M., Dorfler P., Rolink A., and Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17 (1998) 2319-2333
68. Nutt S.L., Urbanek P., Rolink A., and Busslinger M. Essential functions of Pax5 (BSAP) in pro-B cell development: Difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11 (1997) 476-491
69. O'Neill D.W., Schoetz S.S., Lopez R.A., Castle M., Rabinowitz L., Shor E., Krawchuk D., Goll M.G., Renz M., Seelig H.P., et al. An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol. Cell. Biol. 20 (2000) 7572-7582
70. O'Riordan M., and Grosschedl R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11 (1999) 21-31
71. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180 (1994) 1955-1960
72. Polli M., Dakic A., Light A., Wu L., Tarlinton D.M., and Nutt S.L. The development of functional B lymphocytes in conditional PU.1 knock-out mice. Blood 106 (2005) 2083-2090
73. Reya T., O'Riordan M., Okamura R., Devaney E., Willert K., Nusse R., and Grosschedl R. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13 (2000) 15-24
74. Roessler S., Gyory I., Imhof S., Spivakov M., Williams R.R., Busslinger M., Fisher A.G., and Grosschedl R. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol. Cell. Biol. 27 (2007) 579-594
75. Rolink A.G., Nutt S.L., Melchers F., and Busslinger M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401 (1999) 603-606
76. Rosenbauer F., Owens B.M., Yu L., Tumang J.R., Steidl U., Kutok J.L., Clayton L.K., Wagner K., Scheller M., Iwasaki H., et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38 (2006) 27-37
77. Rumfelt L.L., Zhou Y., Rowley B.M., Shinton S.A., and Hardy R.R. Lineage specification and plasticity in CD19- early B cell precursors. J. Exp. Med. 203 (2006) 675-687
78. Sabbattini P., and Dillon N. The lambda5-VpreB1 locus-a model system for studying gene regulation during early B cell development. Semin. Immunol. 17 (2005) 121-127
79. Satterwhite E., Sonoki T., Willis T.G., Harder L., Nowak R., Arriola E.L., Liu H., Price H.P., Gesk S., Steinemann D., et al. The BCL11 gene family: Involvement of BCL11A in lymphoid malignancies. Blood 98 (2001) 3413-3420
80. Schilham M.W., Oosterwegel M.A., Moerer P., Ya J., de Boer P.A., van de Wetering M., Verbeek S., Lamers W.H., Kruisbeek A.M., Cumano A., and Clevers H. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380 (1996) 711-714
81. Schlissel M.S. Regulation of activation and recombination of the murine Igkappa locus. Immunol. Rev. 200 (2004) 215-223
82. Schwarz B.A., Sambandam A., Maillard I., Harman B.C., Love P.E., and Bhandoola A. Selective thymus settling regulated by cytokine and chemokine receptors. J. Immunol. 178 (2007) 2008-2017
83. Scott E.W., Simon M.C., Anastasi J., and Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994) 1573-1577
84. Seet C.S., Brumbaugh R.L., and Kee B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199 (2004) 1689-1700
85. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2 (2001) 827-837
86. Sigvardsson M., O'Riordan M., and Grosschedl R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7 (1997) 25-36
87. Sitnicka E., Brakebusch C., Martensson I.L., Svensson M., Agace W.W., Sigvardsson M., Buza-Vidas N., Bryder D., Cilio C.M., Ahlenius H., et al. Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis. J. Exp. Med. 198 (2003) 1495-1506
88. Sitnicka E., Bryder D., Theilgaard-Monch K., Buza-Vidas N., Adolfsson J., and Jacobsen S.E. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17 (2002) 463-472
89. Smith E.M., Gisler R., and Sigvardsson M. Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression. J. Immunol. 169 (2002) 261-270
90. Souabni A., Cobaleda C., Schebesta M., and Busslinger M. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17 (2002) 781-793
91. Staal F.J., and Clevers H.C. WNT signalling and haematopoiesis: A WNT-WNT situation. Nat. Rev. Immunol. 5 (2005) 21-30
92. Tagoh H., Ingram R., Wilson N., Salvagiotto G., Warren A.J., Clarke D., Busslinger M., and Bonifer C. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction. EMBO J. 25 (2006) 1070-1080
93. Thompson E.C., Cobb B.S., Sabbattini P., Meixlsperger S., Parelho V., Liberg D., Taylor B., Dillon N., Georgopoulos K., Jumaa H., et al. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 26 (2007) 335-344
94. Traver D., and Akashi K. Lineage commitment and developmental plasticity in early lymphoid progenitor subsets. Adv. Immunol. 83 (2004) 1-54
95. Traver D., Akashi K., Manz M., Merad M., Miyamoto T., Engleman E.G., and Weissman I.L. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science 290 (2000) 2152-2154
96. Trinh L.A., Ferrini R., Cobb B.S., Weinmann A.S., Hahm K., Ernst P., Garraway I.P., Merkenschlager M., and Smale S.T. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev. 15 (2001) 1817-1832
97. Vosshenrich C.A., Cumano A., Muller W., Di Santo J.P., and Vieira P. Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat. Immunol. 4 (2003) 773-779
98. Wang J.H., Nichogiannopoulou A., Wu L., Sun L., Sharpe A.H., Bigby M., and Georgopoulos K. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5 (1996) 537-549
99. Xue H.H., Bollenbacher J., Rovella V., Tripuraneni R., Du Y.B., Liu C.Y., Williams A., McCoy J.P., and Leonard W.J. GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells. Nat. Immunol. 5 (2004) 1036-1044
100. Xue H.H., Bollenbacher-Reilley J., Wu Z., Spolski R., Jing X., Zhang Y.C., McCoy J.P., and Leonard W.J. The transcription factor GABP is a critical regulator of B lymphocyte development. Immunity 26 (2007) 421-431
101. Ye M., Ermakova O., and Graf T. PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch. J. Exp. Med. 202 (2005) 1411-1422
102. Yoshida T., Ng S.Y., Zuniga-Pflucker J.C., and Georgopoulos K. Early hematopoietic lineage restrictions directed by Ikaros. Nat. Immunol. 7 (2006) 382-391
103. Zhang Z., Cotta C.V., Stephan R.P., deGuzman C.G., and Klug C.A. Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage. EMBO J. 22 (2003) 4759-4769
104. Zhuang Y., Cheng P., and Weintraub H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16 (1996) 2898-2905